Table 4 Scenario analysis
From: The cost-effectiveness of the Argus II retinal prosthesis in Retinitis Pigmentosa patients
Scenario analysis with constant costs for all Markov states (no cost reduction) | ||||
|---|---|---|---|---|
Time horizon 25 years | ||||
Deterministic | Probabilistic | |||
Mean of 1000 simulations | ||||
Intervention | Disc costs | Disc QALYs | Disc costs | Disc QALYs |
Argus II | 293,807 | 7.34 | 294,083 | 7.35 |
CAU | 201,094 | 4.44 | 200,995 | 4.43 |
Increment | 92,712 | 2.91 | 93,088 | 2.93 |
ICERs | 31,890 | 31,822 | ||
Time horizon 20 years | ||||
Deterministic | Probabilistic | |||
Mean of 1000 simulations | ||||
Intervention | Disc costs | Disc QALYs | Disc costs | Disc QALYs |
Argus II | 265,906 | 6.31 | 266,216 | 6.32 |
CAU | 173,408 | 3.82 | 173,323 | 3.82 |
Increment | 92,498 | 2.49 | 92,893 | 2.50 |
ICERs | 37,174 | 37,117 | ||
Time horizon 10 years | ||||
Deterministic | Probabilistic | |||
Mean of 1000 simulations | ||||
Intervention | Disc costs | Disc QALYs | Disc costs | Disc QALYs |
Argus II | 193,336 | 3.59 | 193,730 | 3.59 |
CAU | 101,473 | 2.24 | 101,423 | 2.23 |
Increment | 91,864 | 1.35 | 92,307 | 1.36 |
ICERs | 68,096 | 68,089 | ||